Target intelligence / Profile preview

Mucin layer and epithelial glycocalyx

Molecular classification
Other (Heterogeneous composite of mucins, proteoglycans, glycoproteins)
01

Overview

The mucin layer and epithelial glycocalyx jointly represent the first line of defense on mucosal surfaces. The **mucin layer** is formed predominantly by secreted, gel-forming mucins (e.g., MUC5AC, MUC5B in airways; MUC2 in intestine) and functions as a mobile, viscoelastic gel that traps pathogens and particulates[1][9]. Beneath this, the **epithelial glycocalyx** is a dense, carbohydrate-rich mesh of membrane-tethered mucins (e.g., MUC1, MUC3, MUC4, MUC16, MUC12, MUC17) and glycoproteins projecting from the apical surface of epithelial cells[1][3][7][9]. This glycocalyx provides a highly selective and more static barrier, supports the mucus gel above it, and participates in cellular signaling and defense mechanisms, including serving as a sensor to modulate inflammation, proliferation, and apoptosis[3][7][9]. Rather than a discrete molecular target, the mucin layer and epithelial glycocalyx constitute a **complex, non-redundant, multilayered protective system**, disruption or dysfunction of which is implicated in a spectrum of diseases affecting mucosal environments.

Other names
mucosal surface barriermucus-glycocalyx complexmucin-glycocalyx barrierepithelial surface glycocalyx
02

Mechanism of action

Mucolytics: disrupt disulfide bonds or DNA/proteins in mucus to reduce viscosity Glycocalyx stabilizers: protect or restore glycan structures

03

Biological functions

Barrier to pathogens and particulatesLubrication of epithelial surfacesModulation of immune responseSignal transduction (via constituent mucins)Maintenance of tissue hydration and ion homeostasis
04

Disease associations

Infection (as a barrier to pathogens, and altered in infection)InflammationCancer (protection, but also changes supporting metastasis)Other (dry eye disease, cystic fibrosis, inflammatory bowel diseases)
05

Safety considerations

No direct therapeutics targeting "mucin layer and glycocalyx" as a single entity; indirect approaches can affect epithelial integrity or increase infection risk by breaking down the barrier
06

Interacting drugs

N-acetylcysteine (mucolytic)

2 more in the full profile.

07

Biomarkers

Levels of secreted mucins (e.g., MUC5AC, MUC5B, MUC2)Glycocalyx thickness (imaged in clinical research)Shedding fragments of specific membrane mucins (e.g., MUC1, MUC16)

Beyond the preview

Go deeper on Mucin layer and epithelial glycocalyx.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucin layer and epithelial glycocalyx.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call